O.K., got some news. From what I was told, earnings came out on
July 31. I think that is around the day that it dropped 5 points.
Earnings were (and these numbers are from memory, hence, only
apporximate) $0.30 per share, up from $0.19 the previous quarter.
Good, but I dont think they met expectations, whatever those were. I
have also learned that they are expanding operations and that FDA
approval may be only a year to year and a half off. Going by the
general formula of determining stock prices, I dont think that this
is a low $20's stock. Volume has been up drastically too. If I were
not in for the long-term, I would have dumped it when it reached the
mid 40's a few weeks after it came out. Im into investing, not
gambeling.
jeff |
